These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7577078)

  • 1. Epidermal growth factor receptor expression by northern analysis and immunohistochemistry in benign and malignant prostatic tumours.
    Harper ME; Goddard L; Glynne-Jones E; Peeling WB; Griffiths K
    Eur J Cancer; 1995; 31A(9):1492-7. PubMed ID: 7577078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues.
    Ibrahim GK; Kerns BJ; MacDonald JA; Ibrahim SN; Kinney RB; Humphrey PA; Robertson CN
    J Urol; 1993 Jan; 149(1):170-3. PubMed ID: 7678041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, premalignant, and malignant prostate tissue.
    Turkeri LN; Sakr WA; Wykes SM; Grignon DJ; Pontes JE; Macoska JA
    Prostate; 1994 Oct; 25(4):199-205. PubMed ID: 7521960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia.
    Maygarden SJ; Strom S; Ware JL
    Arch Pathol Lab Med; 1992 Mar; 116(3):269-73. PubMed ID: 1371380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate.
    Mellon K; Thompson S; Charlton RG; Marsh C; Robinson M; Lane DP; Harris AL; Horne CH; Neal DE
    J Urol; 1992 Feb; 147(2):496-9. PubMed ID: 1370701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ hybridization for epidermal growth factor receptor (EGFR) external domain transcripts in prostatic adenocarcinoma.
    Montone KT; Tomaszewski JE
    J Clin Lab Anal; 1993; 7(3):188-95. PubMed ID: 7685381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue.
    Glynne-Jones E; Goddard L; Harper ME
    Hum Pathol; 1996 Jul; 27(7):688-94. PubMed ID: 8698313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary.
    Wang DP; Konishi I; Koshiyama M; Nanbu Y; Iwai T; Nonogaki H; Mori T; Fujii S
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):393-400. PubMed ID: 1360720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies.
    Hakalahti L; Vihko P; Henttu P; Autio-Harmainen H; Soini Y; Vihko R
    Int J Cancer; 1993 Oct; 55(4):590-7. PubMed ID: 7691762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of the expression of epidermal growth factor receptor in benign prostatic hypertrophy, prostatic intraepithelial neoplasia and prostatic carcinoma.
    Rana S; Sen R; Kalra R; Arora B; Sharma P; Gahlawat S
    Indian J Pathol Microbiol; 2006 Oct; 49(4):495-9. PubMed ID: 17183836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
    Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential immunoreactivity of transforming growth factor alpha in benign, dysplastic and malignant prostatic tissues.
    Robertson CN; Roberson KM; Herzberg AJ; Kerns BJ; Dodge RK; Paulson DF
    Surg Oncol; 1994 Aug; 3(4):237-42. PubMed ID: 7530564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta 1 expression in benign and malignant prostatic tumors.
    Glynne-Jones E; Harper ME; Goddard L; Eaton CL; Matthews PN; Griffiths K
    Prostate; 1994 Oct; 25(4):210-8. PubMed ID: 7521962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
    Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
    J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate.
    Ravindranath N; Wion D; Brachet P; Djakiew D
    J Androl; 2001; 22(3):432-43. PubMed ID: 11330643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of c-erbB-2 and epidermal growth factor receptor in stage A1 (T1a) prostatic adenocarcinoma.
    Fox SB; Persad RA; Coleman N; Day CA; Silcocks PB; Collins CC
    Br J Urol; 1994 Aug; 74(2):214-20. PubMed ID: 7921940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of epidermal growth factor receptor mRNA levels in normal, benign hyperplastic and carcinomatous prostate.
    Kumar VL; Majumder PK; Gujral S; Kumar V
    Cancer Lett; 1998 Dec; 134(2):177-80. PubMed ID: 10025878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor and transforming growth factor alpha expression in human ovarian carcinomas.
    Kohler M; Bauknecht T; Grimm M; Birmelin G; Kommoss F; Wagner E
    Eur J Cancer; 1992; 28A(8-9):1432-7. PubMed ID: 1515265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of transforming growth factor alpha (TGFalpha) and epidermal growth factor receptor (EGFR) in sex hormone-induced prostatic dysplasia and the growth of an androgen-independent transplantable carcinoma of the prostate.
    Kaplan PJ; Leav I; Greenwood J; Kwan PW; Ho SM
    Carcinogenesis; 1996 Dec; 17(12):2571-9. PubMed ID: 9006091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
    Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
    J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.